Nicholas L. Woolf

Nicholas L. Woolf

Corporate Officer/Principal bei
Association of Chartered Certified Accountants (Australia)
58 Jahre
Health Technology
Consumer Services
Finance

Profil

Nicholas L.
Woolf
is a member of the Association of Chartered Certified Accountants (Australia).
He was the Chief Executive Officer of AusCann Group Holdings Ltd. from 2020 to 2021.
He was also the Chief Executive Officer of Proteolytics Pty Ltd. He served as the Executive Director & Chief Business Officer of Oxford Biomedica Plc from 2005 to 2010.
From 2010 to 2013, he was the CFO, Executive Director & VP-Corporate Development of PYC Therapeutics Ltd. He was the Chief Business Officer of Arovella Therapeutics Ltd. from 2013 to 2018.
He was an Analyst at ABN AMRO Bank NV (Broker Old) in 2005.
Woolf is a graduate of the University of Oxford.
Currently, he is a member of the Association of Chartered Certified Accountants (Australia).

Aktive Positionen von Nicholas L. Woolf

UnternehmenPositionBeginn
Association of Chartered Certified Accountants (Australia)
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Nicholas L. Woolf

UnternehmenPositionEnde
AUSCANN GROUP HLDGS Vorstandsvorsitzender 18.03.2021
AROVELLA THERAPEUTICS LIMITED Corporate Officer/Principal 24.07.2018
PYC THERAPEUTICS LIMITED Finanzdirektor/CFO 30.09.2013
OXFORD BIOMEDICA PLC Direktor/Vorstandsmitglied 30.06.2010
Analyst-Equity 17.01.2005
Sehen Sie sich die Erfahrung von Nicholas L. Woolf im Detail an

Ausbildung von Nicholas L. Woolf

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

19

Beziehungen ersten Grades

8

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen8

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Association of Chartered Certified Accountants (Australia)

Health Technology

Proteolytics Pty Ltd.

  1. Börse
  2. Insiders
  3. Nicholas L. Woolf